Laurent Cronier

Dr. Laurent Cronier

CNRS ERL7003, Laboratory Signalisation et Transports Ioniques Membranaires (STIM), University of Poitiers
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2009 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
LCLaurent Cronier
Laurent Cronier
SCSophie Crespin
Sophie Crespin
PSPierre-Olivier Strale
Pierre-Olivier Strale
NDNorah Defamie
Norah Defamie
Marc MESNILMarc MESNIL
Marc MESNIL
Cancer was one of the first pathologies to be associated with gap-junction defect. Despite the evidence accumulated over the last 40-year period, the molecular involvement of gap junctions and their structural proteins (connexins) in cancer has not been elucidated. The lack of a satisfying explanation may come from the complexity of the disease, evolving through various stages during tumor progression, with cancer cells exhibiting different phenotypes. Here, the question of the involvement of gap junctions has been readdressed by considering the connexin expression/function level at different fundamental stages of carcinogenesis (cell proliferation, cell invasion, and cancer cell dissemination). By performing this analysis, it becomes clear that gap junctions are probably differently involved, depending on the stage of the cancer progression considered. In particular, the most recent data suggest that connexins may act on cell growth by controlling gene expression through a variety of processes (independent of or dependent on the gap-junctional communication capacity). During invasion, connexins have been demonstrated to enhance adherence of cancer cells to the stroma, migration, and probably their dissemination by establishing communication with the endothelial barrier. All these data present a complex picture of connexins in various functions, depending on the cell phenotype.

1 January 2002 in Endocrine
Verified
Journal Article
Closed access
PDF file
AMAndre Malassine
Andre Malassine
LCLaurent Cronier
Laurent Cronier

15 August 2003 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
JFJean-Louis Frendo
Jean-Louis Frendo
LCLaurent Cronier
Laurent Cronier
GBGwladys Bertin
Gwladys Bertin
JGJean Guibourdenche
Jean Guibourdenche
MVMichel Vidaud
Michel Vidaud
AMAndré Malassiné
André Malassiné
The syncytiotrophoblast is the principal component of the human placenta involved in feto-maternal exchanges and hormone secretion. The syncytiotrophoblast arises from the fusion of villous cytotrophoblasts. We recently showed that functional gap junctional intercellular communication(GJIC) is an important prerequisite for syncytiotrophoblast formation and that connexin 43 (Cx43) is present in cytotrophoblasts and in the syncytiotrophoblast. To determine whether Cx43 is directly involved in trophoblast fusion, we used an antisense strategy in primary cultures of human villous cytotrophoblasts that spontaneously differentiate into the syncytiotrophoblast by cell fusion. We assessed the morphological and functional differentiation of trophoblasts by desmoplakin immunostaining, by quantifying hCG (human chorionic gonadotropin) production and by measuring the expression of specific trophoblast genes (hCG and HERV-W). Furthermore, we used the gap-FRAP (fluorescence recovery after photobleaching) method to investigate functional GJIC. Cytotrophoblasts treated with Cx43 antisense aggregated and fused poorly. Furthermore, less HERV-W env mRNA, hCGβ mRNA and hCG secretion were detected in Cx43 antisense-treated cytotrophoblasts than in cells treated with scrambled antisense. Treatment with Cx43 antisense dramatically reduced the percentage of coupled trophoblast cells. Taken together, these results suggest that Cx43 is directly involved in human trophoblast cell-cell communication, fusion and differentiation.

26 June 2013 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
DTDominique Thuringer
Dominique Thuringer
GJGaetan Jego
Gaetan Jego
GWGuillaume Wettstein
Guillaume Wettstein
OTOlivier Terrier
Olivier Terrier
LCLaurent Cronier
Laurent Cronier
GCGarrido Carmen
Garrido Carmen
The heat‐shock protein 27 (HSP27) is up‐regulated in tumor cells and released in their microenvironment. Here, we show that extracellular HSP27 has a proangiogenic effect evidenced on chick chorioallantoic membrane. To explore this effect, we test the recombinant human protein (rhHSP27) at physiopathological doses (0.1–10 μg/ml) onto human microvascular endothelial cells (HMECs) grown as monolayers or spheroids. When added onto HMECs, rhHSP27 dose‐dependently accelerates cell migration (with a peak at 5 (μg/ml) and favors spheroid sprouting within 12‐24 h. rhHSP27 increases VEGF gene transcription and promotes secretion of VEGF‐activating VEGF receptor type 2. Increased VEGF transcription is related to NF‐κB activation in 30 min. All of these effects are initiated by rhHSP27 interaction with Toll‐like receptor 3 (TLR3). Such an interaction can be detected by immunoprecipitation but does not seem to be direct, as we failed to detect an interaction between rhHSP27 and monomeric TLR3 by SPR analysis. rhHSP27 is rapidly internalized with a pool of TLR3 to the endosomal compartment (within 15–30 min), which is required for NF‐κB activation in a cytosolic Ca 2+ ‐dependent manner. The HSP27/TLR3 interaction induces NF‐κB activation, leading to VEGF‐mediated cell migration and angiogenesis. Such a pathway provides alternative targets for antiangiogenic cancer therapy.—Thuringer, D., Jego, G., Wettstein, G., Terrier, O., Cronier, L., Yousfi, N., Hébrard, S., Bouchot, A., Hazoumé, A., Joly, A‐L., Gleave, M., Rosa‐Calatrava, M., Solary, E., and Garrido, C., Extracellular HSP27 mediates angiogenesis through Toll‐like receptor 3. FASEB J. 27, 4169–4183 (2013). www.fasebj.org

1 June 2010 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Open access
PDF file
GPGuillaume Pidoux
Guillaume Pidoux
PGPascale Gerbaud
Pascale Gerbaud
SGSédami Gnidehou
Sédami Gnidehou
MGMichael Grynberg
Michael Grynberg
GGGraziello Geneau
Graziello Geneau
JFJean-Louis Frendo
Jean-Louis Frendo
Trophoblastic cell-cell fusion is an essential event required during human placental development. Several membrane proteins have been described to be directly involved in this process, including connexin 43 (Cx43), syncytin 1 (Herv-W env), and syncytin 2 (Herv-FRD env glycoprotein). Recently, zona occludens (ZO) proteins (peripheral membrane proteins associated with tight junctions, adherens junctions, and gap junctions) were shown to be involved in mouse placental development. Moreover, zona occludens 1 (ZO-1) was localized mainly at the intercellular boundaries between human trophoblastic cells. Therefore the role of ZO-1 in the dynamic process of human trophoblastic cell-cell fusion was investigated using primary trophoblastic cells in culture. In vitro as in situ, ZO-1 was localized mainly at the intercellular boundaries between trophoblastic cells where its expression substantially decreased during differentiation and during fusion. At the same time, Cx43 was localized at the interface of trophoblastic cells and its expression increased during differentiation. To determine a functional role for ZO-1 during trophoblast differentiation, small interfering RNA (siRNA) was used to knock down ZO-1 expression. Cytotrophoblasts treated with ZO-1 siRNA fused poorly, but interestingly, decreased Cx43 expression without altering the functionality of trophoblastic cell-cell communication as measured by relative permeability time constant determined using gap-FRAP experiments. Because kinetics of Cx43 and ZO-1 proteins show a mirror image, a potential association of these two proteins was investigated. By using coimmunoprecipitation experiments, a physical interaction between ZO-1 and Cx43 was demonstrated. These results demonstrate that a decrease in ZO-1 expression reduces human trophoblast cell-cell fusion and differentiation.

1 September 2001 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
NDNorah Defamie
Norah Defamie
BMBaharia Mograbi
Baharia Mograbi
CRCyril Roger
Cyril Roger
LCLaurent Cronier
Laurent Cronier
AMAndré Malassine
André Malassine
GPGeorges Pointis
Georges Pointis
Lindane (γ-hexachlorocyclohexane) is a lipid-soluble pesticide that exerts carcinogenic and reprotoxic properties. The mechanisms by which lindane alters testicular function are unclear. Sertoli cells control germ cell proliferation and differentiation through cell–cell communication, including gap junction intercellular communication. Using the 42GPA9 Sertoli cell line, we show that lindane, at a non-cytotoxic dose (50 μM), abolished gap junction intercellular communication (GJIC) between adjacent cells. This change was associated with a time-related diminution and redistribution of Cx43 from the membrane to the cytoplasmic perinuclear region. A similar alteration was observed for ZO-1, a tight junction component associated with Cx43, but not for occludin, an integral tight junction protein. After a 24 h lindane exposure, Cx43 and ZO-1 colocalized within the cytoplasm and no modification of non-phosphorylated and phosphorylated isoforms of Cx43 was observed. By double immunofluorescent labelling we demonstrate that the cytoplasmic Cx43 signal was not present in either the endoplasmic reticulum/Golgi apparatus or lysosomes. These results suggest that lindane inhibits GJIC between Sertoli cells and that aberrant Cx43/ZO-1 localization may be responsible for this effect. The alterations in gap junctions induced by lindane in 42GPA9 Sertoli cells are similar to those observed in tumour cells and may be involved in the pathogenesis of neoplastic seminomal proliferation.